ArticleJournal of neuroimmunology2022

Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab.

Ivan Adamec et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.